VanEck Biotech ETF
Health/Biotechnology
BBH
666 THIRD AVENUE, 9TH FLOOR,
NEW YORK , NY, 10017
NEW YORK , NY, 10017
Price
-
$ 151.94
0 %
+0.82
Dec 20, 2024
- Last Close
- Net Assets
-
$479.1M
Feb 22, 2024
- 52-Week High/Low
- $166.4 - $142.74
- Expense Ratio
- -
Link
Directors
Dec 13, 2023- Laurie A. Hesslein
- R. Alastair Short
- Richard D. Stamberger
- Peter J. Sidebottom
- David H. Chow
- Jan F. Van Eck
Chief Compliance Officer
- Francesco Michael Gozzillo
Company Name |
Holding |
| More | 7.24 % |
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | -6.8% | 1.5% | -14.4% | 3.4% | -8.2% | 16.1% |
| Q2 | -2.1% | -3.7% | -10.1% | 15.2% | 27.3% | 0.1% |
| Q3 | - | -0.2% | -3.4% | 0% | -0.9% | -9.2% |
| Q4 | - | 7.1% | 13.5% | -6.1% | 4.8% | 18.2% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0.1% | -8.9% | 2.3% | -4.6% | 5.6% | - | - | - | - | - | - | - |
| 2023 | 5% | -6.8% | 3.7% | -1.5% | -3.2% | 0.9% | 3% | 1.8% | -4.8% | -7.3% | 5.1% | 9% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.1% | 3.5% | -15.6% | 11.8% | 21.5% | 25.9% | -10.7% | 16.5% | -15% | 10.3% | 30.3% |